Navigation Links
Global Pain Management Industry
Date:6/28/2012

NEW YORK, June 28, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

 

Global Pain Management Industry

http://www.reportlinker.com/p087375/Global-Pain-Management-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=General_M

 

This report analyzes the worldwide markets for Pain Management in US$ Million by the following Product Segments: Pain Management Pharmaceuticals, Pain Management Devices, and Pain Management Services. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 117 companies including many key and niche players such as AstraZeneca PLC, Eli Lilly and Company, Endo Pharmaceuticals, GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co., Inc., Novartis Pharmaceuticals Corp., Pfizer, Inc., Wyeth, Purdue Pharma, and Sanofi S.A. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

 

 

 

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1

Disclaimers I-2

Data Interpretation & Reporting Level I-2

Quantitative Techniques & Analytics I-3

Product Definition and Scope of Study I-3

Pain Management Pharmaceuticals I-3

Pain Management Devices I-3

Pain Management Services I-3

 

 

II. EXECUTIVE SUMMARY

 

1. INDUSTRY OVERVIEW II-1

Pain Management Market to Witness Steady Growth II-1

Factors Affecting Pain Management Industry II-1

Challenges Faced II-2

Trends and Issues II-2

Future Prospects Bright for Pain Relieving Drug Market II-2

Generic Drugs Hog the Limelight II-2

Cox II Crisis Tarnishes Industry Growth II-2

Novel Therapies to Propel Opioid and Non-Opioid Therapies II-3

Neuropathic Pain - Still an Underserved Market II-3

Cyclin-dependent kinase 5 (Cdk5) II-4

Drug Dynamics in the Migraine Market II-4

Pain Pathways - Gain a Second Look II-5

Leading Players II-5

Generics to Inundate Pain Management Drug Market Further II-5

Table 1: Leading Players in the Global Pain Management

Pharmaceuticals Market (2011): Market Share Breakdown of

Value Sales for Pfizer, Eli Lilly, Johnson & Johnson, Endo

Pharma, Novartis and Others (includes corresponding

Graph/Chart) II-6

Status of Major Pipeline Drugs for Pain Management II-6

 

2. PRODUCT OVERVIEW II-7

Pain Management: An Overview II-7

Managing Pain II-7

What is Pain? II-7

Assessment of Pain II-8

Pain Management II-8

Pain Management for Neonates II-9

Pain Management in Kids II-9

Pain Management in Older Adult Surgical Patients II-9

Pain Therapeutics - An Introduction II-10

Treatment of Pain II-11

Pharmacologic Method II-11

Non-pharmacological Method II-12

Invasive Procedures II-12

Palliative Care II-13

Alternative Methods II-13

Acupuncture II-13

Biofeedback II-14

Bioelectromagnetic Therapy II-14

Biomagnetism and Magnetotherapy II-14

Guided Imagery II-14

Manual/Massage Therapies II-14

Aromatherapy Massage II-14

Swedish Massage II-15

Deep Tissue Massage II-15

Neuromuscular Therapy II-15

Myofascial Release II-15

Manual Lymph Drainage II-15

Cranial Sacral Therapy II-15

Reflexology II-16

Naturopathy II-16

Relaxation Therapy II-17

Transcendental Meditation II-17

Classification of Pain II-17

Acute Pain II-17

Postoperative pain II-17

Labor pain II-18

Visceral pain II-18

Migraine II-18

Treatment of Migraine II-18

Chronic Pain II-19

Cancer pain II-19

Back Pain II-19

Neuropathic Pain II-20

Arthritic Pain II-20

HIV-Related Pain II-20

Diabetic Neuropathy II-21

Osteo-and Rheumatoid Arthritis Pain II-22

Pain Management Products and Services II-22

Pain Management Pharmaceuticals II-22

Over-the-counter Drugs II-22

Acetaminophen II-22

Aspirin II-22

Ibuprofen II-22

Ketoprofen II-23

Naproxen II-23

Pramoxine II-23

Counterirritants II-23

Triethanolamine Salicylate (Trolamine) II-23

Prescription Drugs II-24

Non-steroidal Anti-Inflammatories (NSAIDs) II-24

Non-opioid Analgesics II-24

Opioid Analgesics II-24

Pain Management Devices II-26

Electrical Spinal Cord Stimulators II-26

Electrical Stimulus Devices II-27

Transcutaneous Electric Nerve Stimulators (TENS) II-27

Patient-Controlled Analgesia Infusion Devices II-27

Pain Management Services II-27

Home Care/Providence Home Health II-27

Providence Hospices II-28

Pain Management Centers and Clinics II-28

Pain Rehabilitation Programs II-28

 

3. REGULATORY ENVIRONMENT II-29

OTC Painkillers to Carry Conspicuous Safety Warnings II-29

Federal Regulatory Norms of Controlled Substances II-29

DEA Regulations II-29

 

4. PRODUCT INNOVATIONS/INTRODUCTIONS II-31

Venus Remedies to Unveil Aceclofenac OD II-31

Sandoz International Launches Metaxalone Tablets in US II-31

Covidien Unveils EXALGO™ Extended-Release Tablets II-31

Bresslergroup Develops Dental Vibe for Pain-Free Dental

Injections II-32

Competitive Technologies Launches Calmare® Medical Device II-32

Victory Pharma Unveils Naprelan Dose Card II-32

BIOLASE Technology Launches Diolase 10™ Diode Laser II-33

Dr. Reddy's Laboratories Unveils Finrid Transdermal Patch II-33

Cumberland Pharmaceuticals Unveils Caldolor® in US II-33

Tenscare Launches Iglove II-34

Piramal Launches BioElectronics' ActiPatch in India II-34

Victory Pharma to Introduce Supplementary NAPRELAN Products II-34

 

5. PRODUCT INNOVATIONS/INTRODUCTIONS - A HISTORIC PERSPECTIVE BUILDER II-36

Lannett Unveils Two New Products II-36

Glenmark Rolls Out Morphine Oral Solution in the US II-36

Acrux Introduces New NSAID Formulations II-36

Amrutanjan Healthcare Relaunches Amrutanjan Pain Balm II-36

ConvaTec Introduces SUR-FIT Natura® Low-Pressure Adaptor II-36

Cosman Medical Launches G4 Four-Output RF Generator II-37

Origin BioMed Unveils Neuragen II-37

Biotanika Health Rolls Out Natural Product Range II-37

B. Braun Medical Introduces Curlin 6000 CMS II-37

Dynatronics Launches DynaPro Spinal Health System II-37

ProEthic Pharmaceuticals Unveils Ibudone II-38

Endo Pharmaceuticals to Introduce New Dosage Strengths of

OPANA®ER II-38

Dr. Reddy's Laboratories Unveils Supanac II-38

Troikaa Pharmaceuticals Rolls Out DYNAPAR AQ 1ml II-38

Janssen-Cilag International to Launch IONSYS™ II-39

Mallinckrodt Introduces Novel Pain Relieving Agent II-39

Shionogi Unveils Cancer Pain Management Drug II-39

NeuroTherm Launches RF Generators for Treatment of Heel Pain II-39

McNeil Brings Chewable TYLENOL® GoTabs Tablets II-40

Barr Unveils Generic Version of ACTIQ® II-40

Orthofix Unveils e-PainCare II-40

Organon Innovates Org 25969 II-40

Orthofix's BREG Division Launches Polar Care Motorized Cold

Therapy System II-40

Zynex Develops New Pain Management Device II-41

 

6. RECENT INDUSTRY ACTIVITY II-42

Grünenthal's Tapentadol Clears European Decentralised Procedure II-42

Stryker to Acquire Pain-Management Device Unit of Boston

Scientific II-42

Axxess Pharma to Ink License Agreement for a New Prescription

Drug II-42

Endo Pharmaceuticals Acquires HealthTronics II-43

Purdue Pharma Secures FDA Approval for Transdermal System II-43

Discus Acquisition Takes Over Outstanding Shares of Javelin

Pharmaceuticals II-43

Cannabis Science to Acquire Montana Pain Management II-43

Roxro Pharma Receives FDA Approval for SPRIX™ Nasal Spray II-44

Ralfinamide Fails to Show Benefits in Phase IIb Trial II-44

NeuroTherm Acquires Smith & Nephew's Interventional Spine Pain

Management Assets II-44

Horizon Therapeutics Merges with Nitec Pharma II-45

Gentiva Takes Over Heart to Heart Hospice II-45

Millennium Laboratories Inks National Agreement with Aetna II-45

PatientsLikeMe Takes Over ReliefInsite.com II-46

TeamHealth Hospital Staffing Firm Acquires Anesthetix Management II-46

CombinatoRx Merges with Neuromed Pharmaceuticals II-46

Roche Licenses P2X31 Receptor Program to Afferent Pharmaceuticals II-47

Lannett Obtains FDA approval for Producing Hydromorphone

Hydrochloride Tablets II-47

Anesiva Inks an Asset Purchase Agreement with PowderJect

Technologies II-47

Millennium Laboratories Inks Agreement with Three Rivers

Provider Network II-47

Cumberland Pharmaceuticals Partners with Phebra to Promote

Caldolor® II-48

Sciele Pharma Acquires Addrenex Pharmaceuticals II-48

Bioniche Pharma Acquires Injectable Drugs from Xanodyne II-48

NeurogesX Obtains FDA Approval for Qutenza™ II-49

Cerimon Acquires Development and Commercialization Rights for

Diclofenac in Europe II-49

Hydra Biosciences Collaborates with Cubist II-49

Zambon Spa Inks a Licensing Agreement with Indena Spa II-50

Pfizer Acquires Wyeth II-50

B. Braun Bags Contract from HealthTrust Purchasing Group II-50

QRxPharma Enters into Partnership with Patheon to Produce

Clinical Supplies II-51

Kimberly-Clark to Acquire I-Flow II-51

Kimberly-Clark Takes Over Pain Management Business of Baylis

Medical II-52

WraSer Pharmaceuticals Purchases Trezix® from e5 Pharma II-52

TorreyPines Therapeutics Merges with Raptor Therapeutics II-52

GSK Enters into Agreement with Dr Reddy's Laboratories II-53

Patterson Medical Acquires DJO's Supply Catalog and

Rehabilitation Equipment Business II-53

Mallinckrodt Acquires Licensing Rights from Neuromed II-53

Nuvo Research Enters into Licensing Agreement with Mallinckrodt II-53

Bederra Plans to Take Over Neogenex II-54

Z-Cube Inks Deal with Yissum II-54

XenaCare Acquires US License for Homeopathic Treatment II-54

Symbios Ropes in Distributors to Market Pain Management

Products Across US II-54

Teikoku Pharma Takes Over Travanti Pharma II-54

Diamyd Licenses Endomorphin Technology II-55

Competitive Technologies and Life Episteme Enters into an

Agreement II-55

Bederra Enters into Collaboration with Pain Management Center II-55

Javelin Pharmaceuticals Signs Agreement with Therabel Pharma II-56

Biotanika Inks Deal with Xymogen II-56

HSR Clears Solvay Pharmaceuticals and Depomed's Licensing

Agreement II-56

BioDelivery Sciences and Meda Ink an Agreement II-56

Endo Pharmaceuticals to Take Over Indevus Pharmaceuticals II-56

 

7. STRATEGIC CORPORATE DEVELOPMENTS - A HISTORIC PERSPECTIVE BUILDER II-57

Actavis US Acquires Kadian II-57

Labopharm Receives Approval from U.S. Food and Drug

Administration II-57

Albert Acquisition Acquires Alpharma II-57

Sosei Group Re-acquires Commercialization Rights for AD 923 II-57

Sun Pharmaceutical Industries Purchases Chattem Chemicals II-57

Piramal Healthcare Inks Agreement with Minrad International II-58

AgION Technologies and Stryker's Instruments Division Enter

into Agreement II-58

Elder Pharmaceuticals and Global Energy Medicines Sign Agreement II-58

Wound Management Technologies to Take Over BioPharma

Management Technologies II-58

NovaMed Purchases Stake in The Center for Specialized Surgery II-59

RxElite Ends Agreement with Minrad International II-59

Johnson & Johnson Receives FDA Approval for Tapentadol II-59

Mundipharma International and Purdue Pharma Ink Alliance with

Infinity II-59

Zynex Obtains CE Mark for IF8100 and IF8000 Pain-Managing Devices II-59

Competitive Technologies and Able Global Healthcare Ink an

Agreement II-59

National Surgical Hospitals Inks New Joint Venture II-60

Getting Ready and Winston Laboratories Merge II-60

Competitive Technologies and Biogene Pharma Ink an Agreement II-60

MEKT and ProtoKinetix Enter into Agreement II-60

Tronics Microsystems Takes Over MedTech Development II-61

NSC Purchases Ardmore Regional Surgery Center and Kenwood

Surgery Center II-61

Mallinckrodt and Purdue Pharma Sign Agreement II-61

Javelin Pharmaceuticals and Baxter Healthcare Enter into

Agreement II-61

Competitive Technologies and Excel Life Sciences Ink an Agreement II-61

Theragenics to Buy NeedleTech Products II-62

Wyeth Consumer Healthcare Inks Agreement with Procter & Gamble II-62

NovaMed Purchases Majority Stake in Interventional Pain

Management Center II-62

Option Care Enterprises Takes Over CuraScript Infusion Pharmacy II-62

Eli Lilly Obtains FDA Approval for Cymbalta® II-63

Curlin Medical Receives Contract from Premier II-63

EUSA Pharma Acquires Cytogen II-63

American Oriental Enters into Alliance with China Aoxing

Pharmaceutical II-63

Treximet Bags Approval from FDA II-64

LMA International Takes Over Breg's Pain Management Operations II-64

Hospira and HealthTrust Purchasing Group Enter into Agreement II-64

Hebei Aoxing Pharmaceutical Purchases Shijiazhuang Lerentang

Pharmaceutical II-64

Bederra Signs Letter of Intent with Lumar Diagnostic Imaging II-65

Integrated Pain Solutions and Devon Health Services Sign

Agreement II-65

Maneesh Pharmaceuticals Purchases Smyle II-65

Eli Lilly and Glenmark Pharmaceuticals Ink an Agreement II-65

Orexo Takes Over Biolipox II-66

ReAble Therapeutics to Acquire Shares of IOMED II-66

Integra LifeSciences Buys Assets of Pain Management Operations

of Physician Industries II-66

CeNeS Obtains IND Clearance for M6G from FDA II-66

Infinity Acquisition Takes Over Life Without Pain II-67

Neuromed to Acquire US Rights for Oros Hydromorphone from Alza II-67

China Aoxing to Acquire Chinese Pharmaceutical Company,

Shijiazhuang Le Ren II-68

Vyteris Holdings to Acquire Lehigh Valley Technologies II-68

Younger America Pockets Life Without Pain II-68

PainCare Divests Center for Pain Management II-69

Grand Slam Acquires IOMED II-69

Ligand Accomplishes Divesture of AVINZA II-69

CeNeS and Ergomed Collaborate for Phase II Trials of NMDA

Antagonist CNS 5161 II-69

Sorenson Secures Approval to Market Ambulatory Infusion Pump

in China II-69

PainCare Pockets CPMASC II-70

Moog Takes Over Mckinley Medical Corp II-70

PainCare Acquires REC, CareFirst Medical Associates II-70

CLL Pharma Acquires Synt:em II-70

AstraZeneca Partners with Pozen to Bring Novel Pain Management

Therapy II-70

Great Outdoors Acquires Somatic Systems Institute II-71

PainCare Partners with Solstice Neurosciences to Offer Pain

Management in CD II-71

Elan Confers Eisai with European Rights of Prialt II-71

Evotec Partners with Apeiron Biologics to Bring Novel Pain

Therapy II-71

Alpaca Enterprises Acquires Neuroscience Therapy Corp II-71

PainCare Holdings Acquires Desert Pain Medicine Group. II-72

Wex Pharma Inks Agreement With Boston Children's Hospital II-72

Glenmark Inks Agreement with LVT to Market Pain Management

Products II-72

EKR Attains North American Marketing Rights for Gelclair II-72

Grand Slam Acquires Cefar Medical II-72

Omeros Acquires Nura II-72

Hospira Inks Agreement with Premier II-73

Pain Therapeutics Enters into Alliance with King Pharmaceuticals II-73

Corgentech Merges with AlgoRx II-73

Elder Pharmaceuticals Ventures into the Indian Pain Management

Market II-73

Xanodyne Acquires Pharmaceutical Assets of aaiPharma II-73

Pro-Dex Acquires Dental Technology From IntraVantage II-74

Encore Medical Acquires Compex Technologies II-74

Sosei Acquires Arakis II-74

Corgentech Signs Definitive Merger Agreement With AlgoRx II-74

Elder Pharmaceuticals Enters into Marketing Agreement with TRB

Chemedica II-75

University Pain Management Center Signs Agreement with Somnia II-75

Entelos and Organon to Extend Rheumatoid Arthritis (RA)

Collaboration II-75

NovaMed Establishes a New Pain Management Center at Indiana II-75

 

8. FOCUS ON SELECT KEY PLAYERS II-76

AstraZeneca Plc. (UK) II-76

Eli Lilly and Company (USA) II-76

Endo Pharmaceuticals (USA) II-76

GlaxoSmithkline Plc. (UK) II-76

Johnson & Johnson (USA) II-77

Merck & Co., Inc. (USA) II-77

Novartis Pharmaceuticals Corp. (USA) II-78

Pfizer, Inc. (USA) II-78

Wyeth (USA) II-78

Purdue Pharma (USA) II-79

Sanofi S.A (France) II-79

 

9. GLOBAL MARKET PERSPECTIVE II-80

Table 2: World Recent Past, Current & Future Analysis for Pain

Management by Geographic Region - US, Canada, Japan, Europe,

Asia-Pacific (excluding Japan), Latin America, and Rest of

World Markets Independently Analyzed with Annual Revenue

Figures in US$ Million for Years 2009 through 2017(includes

corresponding Graph/Chart) II-80

 

Table 3: World Historic Review for Pain Management by

Geographic Region - US, Canada, Japan, Europe, Asia- Pacific

(excluding Japan), Latin America, and Rest of World Markets

Independently Analyzed with Annual Revenue Figures in US$

Million for Years 2003 through 2008(includes corresponding

Graph/Chart) II-81

 

Table 4: World 15-Year Perspective for Pain Management by

Geographic Region - Percentage Breakdown of Annual Revenue for

US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),

Latin America and Rest of World Markets for Years 2003, 2011 &

2017 (includes corresponding Graph/Chart) II-82

 

Table 5: World Recent Past, Current & Future Analysis for Pain

Management Pharmaceuticals by Geographic Region - US, Canada,

Japan, Europe, Asia-Pacific (excluding Japan), Latin America

and Rest of World Markets Independently Analyzed with Annual

Revenue Figures in US$ Million for Years 2009 through 2017

(includes corresponding Graph/Chart) II-83

 

Table 6: World Historic Review for Pain Management

Pharmaceuticals by Geographic Region - US, Canada, Japan,

Europe, Asia-Pacific (excluding Japan), Latin America and Rest

of World Markets Independently Analyzed with Annual Revenue

Figures in US$ Million for Years 2003 through 2008(includes

corresponding Graph/Chart) II-84

 

Table 7: World 15-Year Perspective for Pain Management

Pharmaceuticals by Geographic Region - Percentage Breakdown of

Annual Revenue for US, Canada, Japan, Europe, Asia-Pacific

(Excluding Japan), Latin America and Rest of World Markets for

Years 2003, 2011 & 2017 (includes corresponding Graph/Chart) II-85

 

Table 8: World Recent Past, Current & Future Analysis for Pain

Management Devices by Geographic Region - US, Canada, Japan,

Europe, Asia-Pacific (excluding Japan), Latin America and Rest

of World Markets Independently Analyzed with Annual Revenue

Figures in US$ Million for Years 2009 through 2017(includes

corresponding Graph/Chart) II-86

 

Table 9: World Historic Review for Pain Management Devices by

Geographic Region - US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Latin America and Rest of World Markets

Independently Analyzed with Annual Revenue Figures in US$

Million for Years 2003 through 2008(includes corresponding

Graph/Chart) II-87

 

Table 10: World 15-Year Perspective for Pain Management

Devices by Geographic Region - Percentage Breakdown of Annual

Revenue for US, Canada, Japan, Europe, Asia- Pacific

(ex2008cluding Japan), Latin America and Rest of World Markets

for Years 2003, 2011 & 2017 (includes corresponding

Graph/Chart) II-88

 

Table 11: World Recent Past, Current & Future Analysis for

Pain Management Services by Geographic Region - US, Canada,

Japan, Europe, Asia-Pacific (excluding Japan), Latin America

and Rest of World Markets Independently Analyzed with Annual

Revenue Figures in US$ Million for Years 2009 through

2017(includes corresponding Graph/Chart) II-89

 

Table 12: World Historic Review for Pain Management Services

by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Latin America and Rest of World Markets

Independently Analyzed with Annual Revenue Figures in US$

Million for Years 2003 through 2008(includes corresponding

Graph/Chart) II-90

 

Table 13: World 15-Year Perspective for Pain Management

Services by Geographic Region - Percentage Breakdown of Annual

Revenue for US, Canada, Japan, Europe, Asia- Pacific

(excluding Japan), Latin America and Rest of World Markets for

Years 2003, 2011 & 2017 (includes corresponding Graph/Chart) II-91

 

 

III. MARKET

 

1. THE UNITED STATES III-1

A.Market Analysis III-1

Pain Statistics in the US III-1

Industry Overview III-1

Pain Management Therapies on the Rise III-2

Opioids Pain Management Market to Garner Sizeable Growth III-2

Safety Concerns Restrict Large Scale Adoption III-2

Measures to Thwart Drug Abuse III-3

Market for Cancer Pain Therapeutics III-3

Leading Players/Brands III-3

Table 14: Leading OTC Pain Relievers in the US Market for

Pain Management (2011) - Percentage Breakdown of Value

Sales by Brand for Advil, Tylenol, Aleve, Bayer, Tylenol

PM, Motrin IB, Excedrin, Tylenol Arthritis, Excedrin

Migraine, Private label, and Others (includes corresponding

Graph/Chart) III-3

 

Table 15: Leading Oral Pain Relievers in the US Market for

Pain Management (2011) - Percentage Breakdown of Value

Sales by Brand for Orajel, Anbesol, Baby Orajel, Colgate

Peroxyl, Zilactin, Glyoxide, Hyland's, Dentek Temparin,

Orajel Mouth Aid, and Others (includes corresponding

Graph/Chart) III-4

B.Market Analytics III-5

Table 16: The US Recent Past, Current & Future Analysis for

Pain Management by Product Segment - Pain Management

Pharmaceuticals, Pain Management Devices and Pain Management

Services Markets Independently Analyzed with Annual Revenue

Figures in US$ Million for Years 2009 through 2017 (includes

corresponding Graph/Chart) III-5

 

Table 17: The US Historic Review for Pain Management by

Product Segment - Pain Management Pharmaceuticals, Pain

Management Devices and Pain Management Services Markets

Independently Analyzed with Annual Revenue Figures in US$

Million for Years 2003 through 2008 (includes corresponding

Graph/Chart) III-6

 

Table 18: The US 15-Year Perspective for Pain Management by

Product Segment - Percentage Breakdown of Annual Revenue for

Pain Management Pharmaceuticals, Pain Management Devices and

Pain Management Services Markets for Years 2003, 2011 & 2017

(Includes corresponding graphs/chart) III-7

 

2. CANADA III-8

Market Analytics III-8

Table 19: Canadian Recent Past, Current & Future Analysis

for Pain Management by Product Segment - Pain Management

Pharmaceuticals, Pain Management Devices and Pain Management

Services Markets Independently Analyzed with Annual Revenue

Figures in US$ Million for Years 2009 through 2017 (includes

corresponding Graph/Chart) III-8

 

Table 20: Canadian Historic Review for Pain Management by

Product Segment - Pain Management Pharmaceuticals, Pain

Management Devices and Pain Management Services Markets

Independently Analyzed with Annual Revenue Figures in US$

Million for Years 2003 through 2008 (includes corresponding

Graph/Chart) III-9

 

Table 21: Canadian 15-Year Perspective for Pain Management

by Product Segment - Percentage Breakdown of Annual Revenue

for Pain Management Pharmaceuticals, Pain Management Devices

and Pain Management Services Markets for Years 2003, 2011

&2017 (includes corresponding Graph/Chart) III-10

 

3. JAPAN III-11

Market Analytics III-11

Table 22: Japanese Recent Past, Current & Future Analysis

for Pain Management by Product Segment - Pain Management

Pharmaceuticals, Pain Management Devices and Pain Management

Services Markets Independently Analyzed with Annual Revenue

Figures in US$ Million for Years 2009 through 2017 (includes

corresponding Graph/Chart) III-11

 

Table 23: Japanese Historic Review for Pain Management by

Product Segment - Pain Management Pharmaceuticals, Pain

Management Devices and Pain Management Services Markets

Independently Analyzed with Annual Revenue Figures in US$

Million for Years 2003 through 2008 (includes corresponding

Graph/Chart) III-12

 

Table 24: Japanese 15-Year Perspective for Pain Management

by Product Segment - Percentage Breakdown of Annual Revenue

for Pain Management Pharmaceuticals, Pain Management Devices

and Pain Management Services Markets for Years 2003, 2011 &

2017 (includes corresponding Graph/Chart) III-13

 

4. EUROPE III-14

Market Analytics III-14

Table 25: European Recent Past, Current & Future Analysis

for Pain Management by Geographic Region - France, Germany,

Italy, UK, Spain, Russia & Rest of Europe Markets

Independently Analyzed with Annual Revenue Figures in US$

Million for Years 2009 through 2017 (includes corresponding

Graph/Chart) III-14

 

Table 26: European Historic Review for Pain Management by

Geographic Region - France, Germany, Italy, UK, Spain,

Russia & Rest of Europe Markets Independently Analyzed with

Annual Revenue Figures in US$ Million for Years 2003 through

2008 (includes corresponding Graph/Chart) III-15

 

Table 27: European 15-Year Perspective for Pain Management

by Geographic Region - Percentage Breakdown of Annual

Revenue for France, Germany, Italy, UK, Spain, Russia & Rest

of Europe Markets for Years 2003, 2011 & 2017 (includes

corresponding Graph/Chart) III-16

 

Table 28: European Recent Past, Current & Future Analysis

for Pain Management by Product Segment - Pain Management

Pharmaceuticals, Pain Management Devices and Pain Management

Services Markets Independently Analyzed with Annual Revenue

Figures in US$ Million for Years 2009 through 2017 (includes

corresponding Graph/Chart) III-17

 

Table 29: European Historic Review for Pain Management by

Product Segment - Pain Management Pharmaceuticals, Pain

Management Devices and Pain Management Services Markets

Independently Analyzed With Annual Revenue Figures in US$

Million for Years 2003 through 2008(includes corresponding

Graph/Chart) III-18

 

Table 30: European 15-Year Perspective for Pain Management

by Product Segment - Percentage Breakdown of Annual Revenue

for Pain Management Pharmaceuticals, Pain Management Devices

and Pain Management Services Markets for Years 2003, 2011 &

2017 (includes corresponding Graph/Chart) III-19

 

4a. FRANCE III-20

Market Analytics III-20

Table 31: French Recent Past, Current & Future Analysis for

Pain Management by Product Segment - Pain Management

Pharmaceuticals, Pain Management Devices and Pain Management

Services Markets Independently Analyzed with Annual Revenue

Figures in US$ Million for Years 2009 through 2017 (includes

corresponding Graph/Chart) III-20

 

Table 32: French Historic Review for Pain Management by

Product Segment - Pain Management Pharmaceuticals, Pain

Management Devices and Pain Management Services Markets

Independently Analyzed with Annual Revenue Figures in US$

Million for Years 2003 through 2008(includes corresponding

Graph/Chart) III-21

 

Table 33: French 15-Year Perspective for Pain Management by

Product Segment - Percentage Breakdown of Annual Revenue for

Pain Management Pharmaceuticals, Pain Management Devices and

Years Pain Management Services Markets for Years 2003, 2011 &

2017 (includes corresponding Graph/Chart) III-22

 

4b. GERMANY III-23

Market Analytics III-23

Table 34: German Recent Past, Current & Future Analysis for

Pain Management by Product Segment - Pain Management

Pharmaceuticals, Pain Management Devices and Pain Management

Services Markets Independently Analyzed with Annual Revenue

Figures in US$ Million for Years 2009 through 2017 (includes

corresponding Graph/Chart) III-23

 

Table 35: German Historic Review for Pain Management by

Product Segment - Pain Management Pharmaceuticals, Pain

Management Devices and Pain Management Services Markets

Independently Analyzed with Annual Revenue Figures in US$

Million for Years 2003 through 2008 (includes corresponding

Graph/Chart) III-24

 

Table 36: German 15-Year Perspective for Pain Management by

Product Segment - Percentage Breakdown of Annual Revenue for

Pain Management Pharmaceuticals, Pain Management Devices and

Pain Management Services Markets for Years 2003, 2011 & 2017

(includes corresponding Graph/Chart) III-25

 

4c. ITALY III-26

Market Analytics III-26

Table 37: Italian Recent Past, Current & Future Analysis for

Pain Management by Product Segment - Pain Management

Pharmaceuticals, Pain Management Devices and Pain Management

Services Markets Independently Analyzed with Annual Revenue

Figures in US$ Million for Years 2009 through 2017 (includes

corresponding Graph/Chart) III-26

 

Table 38: Italian Historic Review for Pain Management by

Product Segment - Pain Management Pharmaceuticals, Pain

Management Devices and Pain Management Services Markets

Independently Analyzed with Annual Revenue Figures in US$

Million for Years 2003 through 2008 (includes corresponding

Graph/Chart) III-27

 

Table 39: Italian 15-Year Perspective for Pain Management by

Product Segment - Percentage Breakdown of Annual Revenue for

Pain Management Pharmaceuticals, Pain Management Devices and

Pain Management Services Markets for Years 2003, 2011 & 2017

(includes corresponding Graph/Chart) III-28

 

4d. THE UNITED KINGDOM III-29

A.Market Analysis III-29

Key Statistics Related to Pain Management in the UK III-29

B.Market Analytics III-30

Table 40: The UK Recent Past, Current & Future Analysis for

Pain Management by Product Segment -Pain Management

Pharmaceuticals, Pain Management Devices and Pain Management

Services Markets Independently Analyzed with Annual Revenue

Figures in US$ Million for Years 2009 through 2017 (includes

corresponding Graph/Chart) III-30

 

Table 41: The UK Historic Review for Pain Management by

Product Segment - Pain Management Pharmaceuticals, Pain

Management Devices and Pain Management Services Markets

Independently Analyzed with Annual Revenue Figures in US$

Million for Years 2003 through 2008 (includes corresponding

Graph/Chart) III-31

 

Table 42: The UK 15-Year Perspective for Pain Management by

Product Segment - Percentage Breakdown of Annual Revenue for

Pain Management Pharmaceuticals, Pain Management Devices and

Pain Management Services Markets for Years 2003, 2011 & 2017

(includes corresponding Graph/Chart) III-32

 

4e. SPAIN III-33

Market Analytics III-33

Table 43: Spanish Recent Past, Current & Future Analysis for

Pain Management by Product Segment - Pain Management

Pharmaceuticals, Pain Management Devices and Pain Management

Services Markets Independently Analyzed with Annual Revenue

Figures in US$ Million for Years 2009 through 2017 (includes

corresponding Graph/Chart) III-33

 

Table 44: Spanish Historic Review for Pain Management by

Product Segment - Pain Management Pharmaceuticals, Pain

Management Devices and Pain Management Services Markets

Independently Analyzed with Annual Revenue Figures in US$

Million for Years 2003 through 2008 (includes corresponding

Graph/Chart) III-34

 

Table 45: Spanish 15-Year Perspective for Pain Management by

Product Segment - Percentage Breakdown of Annual Revenue for

Pain Management Pharmaceuticals, Pain Management Devices and

Pain Management Services Markets for Years 2003, 2011 & 2017

(includes corresponding Graph/Chart) III-35

 

4f. RUSSIA III-36

Market Analytics III-36

Table 46: Russian Recent Past, Current & Future Analysis for

Pain Management by Product Segment - Pain Management

Pharmaceuticals, Pain Management Devices and Pain Management

Services Markets Independently Analyzed with Annual Revenue

Figures in US$ Million for Years 2009 through 2017 (includes

corresponding Graph/Chart) III-36

 

Table 47: Russian Historic Review for Pain Management by

Product Segment - Pain Management Pharmaceuticals, Pain

Management Devices and Pain Management Services Markets

Independently Analyzed with Annual Revenue Figures in US$

Million for Years 2003 through 2008 (includes corresponding

Graph/Chart) III-37

 

Table 48: Russian 15-Year Perspective for Pain Management by

Product Segment - Percentage Breakdown of Annual Revenue for

Pain Management Pharmaceuticals, Pain Management Devices and

Pain Management Services Markets for Years 2003, 2011 & 2017

(includes corresponding Graph/Chart) III-38

 

4g. REST OF EUROPE III-39

Market Analytics III-39

Table 49: Rest of Europe Recent Past, Current & Future

Analysis for Pain Management by Product Segment -Pain

Management Pharmaceuticals, Pain Management Devices and Pain

Management Services Markets Independently Analyzed with

Annual Revenue Figures in US$ Million for Years 2009 through

2017 (includes corresponding Graph/Chart) III-39

 

Table 50: Rest of Europe Historic Review for Pain Management

by Product Segment - Pain Management Pharmaceuticals, Pain

Management Devices and Pain Management Services Markets

Independently Analyzed with Annual Revenue Figures in US$

Million for Years 2003 through 2008 (includes corresponding

Graph/Chart) III-40

 

Table 51: Rest of Europe 15-Year Perspective for Pain

Management by Product Segment - Percentage Breakdown of

Annual Revenue for Pain Management Pharmaceuticals, Pain

Management Devices and Pain Management Services Markets for

Years 2003, 2011 &2017 (includes corresponding Graph/Chart) III-41

 

5. ASIA-PACIFIC III-42

A.Market Analysis III-42

India III-42

B.Market Analytics III-42

Table 52: Asia-Pacific Recent Past, Current & Future

Analysis for Pain Management by Product Segment -Pain

Management Pharmaceuticals, Pain Management Devices and Pain

Management Services Markets Independently Analyzed with

Annual Revenue Figures in US$ Million for Years 2009 through

2017 (includes corresponding Graph/Chart) III-42

 

Table 53: Asia-Pacific Historic Review for Pain Management

by Product Segment - Pain Management Pharmaceuticals, Pain

Management Devices and Pain Management Services Markets

Independently Analyzed with Annual Revenue Figures in US$

Million for Years 2003 through 2008 (includes corresponding

Graph/Chart) III-43

 

Table 54: Asia-Pacific 15-Year Perspective for Pain

Management by Product Segment - Percentage Breakdown of

Annual Revenue for Pain Management Pharmaceuticals, Pain

Management Devices and Pain Management Services Markets for

Years 2003, 2011 & 2017 (includes corresponding Graph/Chart) III-44

 

6. LATIN AMERICA III-45

Market Analytics III-45

Table 55: Latin American Recent Past, Current & Future

Analysis for Pain Management by Product Segment -Pain

Management Pharmaceuticals, Pain Management Devices and Pain

Management Services Markets Independently Analyzed with

Annual Revenue Figures in US$ Million for Years 2009 through

2017(includes corresponding Graph/Chart) III-45

 

Table 56: Latin American Historic Review for Pain Management

by Product Segment - Pain Management Pharmaceuticals, Pain

Management Devices and Pain Management Services Markets

Independently Analyzed with Annual Revenue Figures in US$

Million for Years 2003 through 2008(includes corresponding

Graph/Chart) III-46

 

Table 57: Latin American 15-Year Perspective for Pain

Management by Product Segment - Percentage Breakdown of

Annual Revenue for Pain Management Pharmaceuticals, Pain

Management Devices and Pain Management Services Markets for

Years 2003, 2011 & 2017 (includes corresponding Graph/Chart) III-47

 

7. REST OF WORLD III-48

Market Analytics III-48

Table 58: Rest of World Recent Past, Current & Future

Analysis for Pain Management by Product Segment - Pain

Management Pharmaceuticals, Pain Management Devices and Pain

Management Services Markets Independently Analyzed with

Annual Revenue Figures in US$ Million for Years 2009 through

2017 (includes corresponding Graph/Chart) III-48

 

Table 59: Rest of World Historic Review for Pain Management

by Product Segment - Pain Management Pharmaceuticals, Pain

Management Devices and Pain Management Services Markets

Independently Analyzed with Annual Revenue Figures in US$

Million for Years 2003 through 2008(includes corresponding

Graph/Chart) III-49

 

Table 60: Rest of World 15-Year Perspective for Pain

Management by Product Segment - Percentage Breakdown of

Annual Revenue for Pain Management Pharmaceuticals, Pain

Management Devices and Pain Management Services Markets for

Years 2003, 2011 & 2017 (includes corresponding Graph/Chart) III-50

 

 

IV. COMPETITIVE LANDSCAPE

 

Total Companies Profiled: 117 (including Divisions/Subsidiaries - 133)

 

------------------------------------------

Region/Country Players

------------------------------------------

The United States 82

Canada 3

Japan 7

Europe 32

France 4

Germany 4

The United Kingdom 10

Italy 2

Rest of Europe 12

Asia-Pacific (Excluding Japan) 7

Latin America 1

Middle East 1

------------------------------------------

 

 

 

To order this report:

General Medicine and Specialty Medicine Industry: Global Pain Management Industry

 

 

More Market Research Report

 

 

 

Check our Industry Analysis and Insights

 

 

Nicolas Bombourg
Reportlinker
Email: nicolasbombourg@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

 


'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved


Related medicine technology :

1. Pharmaceuticals: Global Industry Almanac, MarketLine
2. Global Information, Inc. Announces New Market Forecasts For Drug Discovery Industry as it Emerges from Recession
3. Global Markets for Enzyme Inhibitors
4. Negative Pressure Wound Therapy (NPWT) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018
5. Genitourinary Drugs: Technologies and Global Markets
6. Marken Announces Global Advisory Board
7. Masimo Deploys Kinaxis RapidResponse for Global Demand and Supply Balancing
8. Asthma and COPD Drug Market Expected to Reach USD 26,965.5 Million Globally in 2017: Transparency Market Research
9. MMRGlobal and Fujitsu Offer Low-Cost System to Digitize Medical Records
10. ResearchMoz: Global Power Wheelchairs Market Will Reach $3.9 Billion by 2018 - Market Research Report
11. Sentry BioPharma Services Invests in Global Clinical Supply Services with -45C Freezer Expansion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... May 24, 2016 Niederländische ... gebracht, die es Ärzten erlaubt, ihre Expertise weltweit ... MDLinking kombiniert Live Streaming mit einer Instant-Messaging-Funktion und ... kommunizieren. Mediziner in Europa, Afrika, Asien und den ... für die Plattform registriert. Information und ...
(Date:5/24/2016)...   , Study met both ... in , Excellent plus Good ... of the ascending colon   ,      ... announced new positive data from the phase III MORA study for ... litre PEG with ascorbate. The study met both primary endpoints showing ...
(Date:5/24/2016)... 2016  NxStage Medical, Inc. (Nasdaq: NXTM ... renal care, today announced that Jeffrey H. Burbank ... following schedule of investor conferences. Where applicable, a webcast ... http://ir.nxstage.com/ .   ... NY           Friday, June 10, 2016 1:30 p.m. ET ...
Breaking Medicine Technology:
(Date:5/27/2016)... ... 27, 2016 , ... With a team of certified experts, ... Aside from its GMP accreditation, Validation Center is also a registered authority of ... and staff. , Validation Center is ISO17025 accredited and only offers its clients ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... and clinical outcomes, hosted members and suppliers for its inaugural Member Conference at ... on their mission of elevating the operational health of America’s healthcare providers. , ...
(Date:5/26/2016)... ... 2016 , ... Cardiac arrhythmia is a common complication following ... survival, reports a team of UPMC researchers in the largest study of its ... Thoracic and Cardiovascular Surgery, provide critical information that will hopefully lead to better ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... An April ... American families. , The 550 employees of Sun Health Senior Living (SHSL) ... Aetna that reduces their doctor and prescription copays for the year, while holding the ...
(Date:5/26/2016)... ... ... The Lung Institute has partnered with the Gulfcoast North Area ... at their clinic in downtown Tampa. The class is complimentary for the public. Register ... a free downloadable 4 Week Smoking Cessation Guide for those who are ...
Breaking Medicine News(10 mins):